Further histological results suggested that the synthesis of PCNA and β-catenin was clearly affected by EGCG in tumor tissues, and both of these proteins are closely linked to the ability of tumor cells to proliferate indefinitely [31], which may explain the inhibition of tumor growth observed in the EGCG-treated groups. The gene discussed is PCNA; the disease is neoplasm.